Why caution is recommended with post-hoc individual patient matching for estimation of treatment effect in parallel-group randomized controlled trials: The case of acute stroke trials

Statistics in Medicine

Volumn 32, Issue 25, 2013, Pages 4467-4481

  Jafari, Nahid ^a   Hearne, John ^a   Churilov, Leonid ^a,b  

^a RMIT UNIVERSITY   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Assignment problem; Individual post hoc matching; Ordinal NNTs; Parallel group RCTs; Stroke

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DATA ANALYSIS; FUNCTIONAL ASSESSMENT; HUMAN; MEDICAL DECISION MAKING; POST HOC ANALYSIS; PROGNOSIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SIMULATION; STATISTICAL MODEL; THERAPY EFFECT; VALIDITY; COMPUTER SIMULATION; CONTROL GROUP; METHODOLOGY; OUTCOME ASSESSMENT; PROCEDURES; REGRESSION ANALYSIS; STANDARDS; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA; STROKE;

COMPUTER SIMULATION; CONTROL GROUPS; HUMANS; MATCHED-PAIR ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RESEARCH DESIGN; SAMPLE SIZE; STROKE;

EID: 84885191077     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5862     Document Type: Article

References (42)

1. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. The American Statistician 1985; 39(1):33-38.
2. Lu B, Zanutto E, Hornik R, Rosenbaum PR. Matching with doses in an observational study of a media campaign against drug abuse. Journal of The American Statistical Association 2001; 96(456):1245-1253.
3. Rosenbaum PR, Silber JH. Matching and thick description in an observational study of mortality after surgery. Biostatistics 2001; 2(2):217-232.
4. Greevy R, Lu B, Silber JH, Rosenbaum PR. Optimal multivariate matching before randomization. Biostatistics 2004; 5(2):263-275.
5. Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. Journal of Clinical Epidemiology 2006; 59(5):437-447.
6. Haviland A, Nagin DS, Rosenbaum PR. Combining propensity score matching and group-based trajectory analysis in an observational study. Psychological Methods 2007; 12(3):247-267.
7. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Statistics in Medicine 2008; 27:2037-2049.
8. Bland JM, Altman DG. Statistics notes: matching. BMJ 1994; 309:1128.
9. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Archives of Neurology 2004; 61:1066-1070.
10. Bath P, Hogg C, Tracy M, Pocock S. Calculation of numbers-needed-to-treat in parallel group trials assessing ordinal outcomes: case examples from acute stroke and stroke prevention. International Journal of Stroke 2011; 6:472-479.
11. Nemhauser GL, Wolsey LA. Integer and Combinatorial Optimization. John Wiley & Sons Ltd: NY, 1999.
12. Sekhon JS. Multivariate and propensity score matching software with automated balance optimization: the matching package for R. Journal of Statistical Software 2011; 42(7):1-52.
13. Wacholder S, Weinberg C. Paired versus two-sample design for a clinical trial of treatments with dichotomous outcome: power considerations. Biometrics 1982; 38:801-812.
14. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. BMJ 1998; 316:690-693.
15. Walter SD. Number needed to treat (NNT): estimation of a measure of clinical benefit. Statistics in Medicine 2001; 20:3947-3962.
16. Liang BA, Lew R, Zivin JA. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues. Archives of Neurology 2008; 65:1429-1433.
17. Dettmann E, Becker C, Schmeiber C. Distance functions for matching in small samples. Computational Statistics and Data Analysis 2011; 55(5):1942-1960.
18. Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. Journal of Economic Surveys 2008; 22(1):31-72.
19. Mahalanobis P. On the generalized distance in statistics, for the classification problem, The National Institute of Sciences of India II(1), 1936; 49-55.
20. Gower JC. A general coefficient of similarity and some of its properties. Biometrics 1971; 27(4):857-871.
21. Rosenbaum PR. Optimal matching for observational studies. The American Statistical Association 1989; 84(408):1024-1032.
22. Ming K, Rosenbaum P. A note on optimal matching with variable controls using the assignment algorithm. Journal of Computational and Graphical Statistics 2001; 10(3):455-463.
23. Gale D, Shapley LS. College admissions and the stability of marriage. The American Mathematical Monthly 1962; 69(1):9-15.
24. Batabyal AA, DeAngelo GJ. To match or not to match: aspects of marital matchmaking under uncertainty. Operations Research Letters 2008; 36(1):94-98.
25. Lerner E. Relationship between matching and assignment problems. Russian Mathematics (Iz VUZ) 2011; 55:27-32.
26. Jovanovic B. Job matching and the theory of turnover. Political Economy 1979; 87:972-990.
27. Drigas A, Kouremenos S, Vrettos S, Vrettaros J, Kouremenos D. An expert system for job matching of the unemployed. Expert Systems with Applications 2004; 26(2):217-224.
28. Wang M, Li H. A research on two-sided matching algorithm between new hired knowledge staff and position requirements. 2011 2nd International Conference on Artificial Intelligence, Management Science and Electronic Commerce (AIMSEC), Zhengzhou, China, 2011; 55-58.
29. Smith BD, Marsh JC. Client-service matching in substance abuse treatment for women with children. Substance Abuse Treatment 2002; 22:161-168.
30. Breslin CF, Gladwin CH, Borsoi D, Cunningham JA. Defacto client-treatment matching: how clinicians make referrals to outpatient treatments for substance use. Evaluation and Program Planning 2000; 23(3):281-291.
31. Steuer RE. Multiple Criteria Optimization: Theory, Computations, and Application. John Wiley & Sons Inc: NY, 1986.
32. Stewart T. A critical survey on the status of multiple criteria decision making theory and practice. Omega 1992; 20(5-6):569-586.
33. Rosenbaum PR, Rubin DB. The bias due to incomplete matching. Biometrics 1985; 41(1):103-116.
34. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine 1995; 333(24):1581-1588.
35. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand pJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM, Epithet Investigators. Effects of alteplase beyond 3h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. The Lancet Neurology 2008; 7(4):299-309.
36. Donnan G, Fisher M, Macleod M, Davis S. Stroke. Lancet 2008; 371:1612-1623.
37. Altman DG, Bland JM. Treatment allocation in controlled trials: why randomise? BMJ 1999; 318(7192):1209-1209.
38. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 9 1999; 319(7211):670-674.
39. Altman DG. Practical Statistics for Medical Research. Chapman and Hall/CRC: London, 1990.
40. Knoflach M, Matosevic B, Rücker M, Furtner M, Mair A, Wille G, Zangerle A, Werner P, Ferrari J, Schmidauer C, Seyfang L, Kiechl S, Willeit J, Austrian Stroke Unit Registry Collaborators. Functional recovery after ischemic stroke-a matter of age: data from the Austrian stroke unit registry. Neurology 2012; 78(4):279-285.
41. IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. The Lancet 2012; 379(9834):2352-2363.
42. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. The Lancet 2010; 375(9727):1695-1703.